文献速递神经肿瘤

立体定向放射外科治疗偶然发现的海绵窦脑膜瘤:一项多机构研究

Stereotactic Radiosurgery for Incidentally Discovered Cavernous Sinus Meningiomas: A Multi-institutional Study.
PubMed 文献 · World Neurosurg · 2021-11-14

这项国际回顾性研究纳入37例(29例男性;平均±标准差年龄55.05±11.56岁)接受 upfront 立体定向放射外科(SRS)治疗的无症状海绵窦脑膜瘤患者,平均±标准差边缘剂量12.27±2.3 Gy;中位临床和影像随访分别为66(IQR 84)和72(IQR 84)个月;末次随访时肿瘤缩小19例(51.35%)、稳定18例(48.65%),SRS相关并发症2例(5.4%)经保守处理。作者结论认为 upfront SRS 是安全有效的选择,可考虑在初诊时进行,若选择观察则应在影像学记录到肿瘤生长时推荐 SRS。

要点

  • 37例无症状海绵窦脑膜瘤接受 upfront SRS,末次随访肿瘤缩小19例(51.35%)、稳定18例(48.65%)。
  • SRS相关并发症2例(5.4%),均经保守处理。
  • 作者认为 upfront SRS 安全有效,初诊时可考虑 SRS;若初始选择观察,影像学记录到肿瘤生长时应推荐 SRS。

核心结论

  • 作者结论认为 upfront SRS 是无症状海绵窦脑膜瘤安全有效的治疗选择,初诊时可考虑 SRS;若初始选择观察,影像学记录到肿瘤生长时应推荐 SRS。

研究设计与样本

  • 国际回顾性研究,纳入接受 upfront SRS 治疗的无症状海绵窦脑膜瘤患者37例(29例男性;平均±标准差年龄55.05±11.56岁)。
  • 平均±标准差边缘剂量为12.27±2.3 Gy;中位临床随访66(IQR 84)个月,中位影像随访72(IQR 84)个月。

主要发现

  • 末次随访时,肿瘤缩小19例(51.35%),肿瘤稳定18例(48.65%)。
  • SRS相关并发症2例(5.4%),均经保守处理。

关键数值与推荐

  • 平均±标准差边缘剂量12.27±2.3 Gy;肿瘤缩小19例(51.35%)vs 肿瘤稳定18例(48.65%);SRS相关并发症2例(5.4%)。

临床怎么用

  • 作者认为 upfront SRS 是安全有效的治疗选择,初诊时可考虑 SRS;若初始选择观察,影像学记录到肿瘤生长时应推荐 SRS。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The initial management of asymptomatic, incidentally discovered, cavernous sinus (CS) meningiomas remains incompletely defined. This study evaluated the safety and efficacy of stereotactic radiosurgery (SRS) for patients presenting with an asymptomatic CS meningioma. METHODS: This is an international, retrospective study included patients treated with upfront SRS for an asymptomatic CS meningioma. Local tumor control, tumor and SRS-related complications, and the development of new neurologic deficits after SRS were evaluated. RESULTS: A total of 37 patients (29 men; mean ± SD age: 55.05 ± 11.56 years) treated with upfront SRS for an asymptomatic, CS meningioma were included in the study. The mean ± SD margin dose was 12.27 ± 2.3 Gy. The median clinical and radiological follow-up periods were 66 (IQR 84) and 72 (IQR 84) months, respectively. At the last follow-up, tumor regression and stability were noted in 19 (51.35%) and 18 (48.65%) of CS meningiomas, respectively. SRS-related complications occurred in 2 patients (5.4%) and were managed conservatively. CONCLUSIONS: Upfront SRS is a safe and effective treatment option for asymptomatic CS meningiomas. SRS may be considered at the time of initial diagnosis of a CS meningioma. If observation is the initial management chosen, SRS should be recommended when CS meningioma growth is documented on follow-up imaging.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Pikis S, Mantziaris G, Samanci Y, et al. Stereotactic Radiosurgery for Incidentally Discovered Cavernous Sinus Meningiomas: A Multi-institutional Study. World Neurosurg. 2021. PMID: 34785361. doi:10.1016/j.wneu.2021.11.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。